161 related articles for article (PubMed ID: 19485933)
1. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms.
Maldonado C; Soni CV; Todnem ND; Pushpakumar S; Rosenberger D; Givvimani S; Villafane J; Tyagi SC
Curr Vasc Pharmacol; 2010 Jan; 8(1):64-74. PubMed ID: 19485933
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
Moshal KS; Metreveli N; Frank I; Tyagi SC
Curr Vasc Pharmacol; 2008 Apr; 6(2):84-92. PubMed ID: 18393909
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.
Rosenberger D; Moshal KS; Kartha GK; Tyagi N; Sen U; Lominadze D; Maldonado C; Roberts AM; Tyagi SC
Arch Physiol Biochem; 2006; 112(4-5):219-27. PubMed ID: 17178594
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.
Vacek TP; Vacek JC; Tyagi SC
Arch Physiol Biochem; 2012 Feb; 118(1):31-42. PubMed ID: 22181043
[TBL] [Abstract][Full Text] [Related]
5. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.
Moshal KS; Kumar M; Tyagi N; Mishra PK; Metreveli N; Rodriguez WE; Tyagi SC
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H887-92. PubMed ID: 19181966
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Steed MM; Tyagi SC
Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
[TBL] [Abstract][Full Text] [Related]
7. Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.
Tawfik A; Samra YA; Elsherbiny NM; Al-Shabrawey M
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32751132
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia.
Jeremic J; Nikolic Turnic T; Zivkovic V; Jeremic N; Milosavljevic I; Srejovic I; Obrenovic R; Jancic S; Rakocevic M; Matic S; Djuric D; Jakovljevic V
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):683-693. PubMed ID: 29509296
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
Moshal KS; Tipparaju SM; Vacek TP; Kumar M; Singh M; Frank IE; Patibandla PK; Tyagi N; Rai J; Metreveli N; Rodriguez WE; Tseng MT; Tyagi SC
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H890-7. PubMed ID: 18567713
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice.
Rosenberger D; Gargoum R; Tyagi N; Metreveli N; Sen U; Maldonado C; Tyagi S
Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):492-8. PubMed ID: 20227264
[TBL] [Abstract][Full Text] [Related]
11. Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia.
Moshal KS; Camel CK; Kartha GK; Steed MM; Tyagi N; Sen U; Kang YJ; Lominadze D; Maldonado C; Tyagi SC
Curr Neurovasc Res; 2007 Nov; 4(4):289-94. PubMed ID: 18045155
[TBL] [Abstract][Full Text] [Related]
12. Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.
Tyagi N; Vacek JC; Givvimani S; Sen U; Tyagi SC
J Recept Signal Transduct Res; 2010 Apr; 30(2):78-87. PubMed ID: 20170426
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and heart failure: an overview.
Vizzardi E; Bonadei I; Zanini G; Frattini S; Fiorina C; Raddino R; Dei Cas L
Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):15-21. PubMed ID: 19149701
[TBL] [Abstract][Full Text] [Related]
14. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Austin RC; Lentz SR; Werstuck GH
Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia Alters Sinoatrial and Atrioventricular Nodal Function: Role of Magnesium in Attenuating These Effects.
Soni CV; Tyagi SC; Todnem ND; Givvimani S; Pushpakumar SB; Villafane J; Maldonado C
Cell Biochem Biophys; 2016 Mar; 74(1):59-65. PubMed ID: 26972302
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of sudden cardiac death: oxidants and metabolism.
Yang KC; Kyle JW; Makielski JC; Dudley SC
Circ Res; 2015 Jun; 116(12):1937-55. PubMed ID: 26044249
[TBL] [Abstract][Full Text] [Related]
17. Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats.
Hagar HH
Pharmacol Res; 2002 Sep; 46(3):213-19. PubMed ID: 12220963
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs are involved in homocysteine-induced cardiac remodeling.
Mishra PK; Tyagi N; Kundu S; Tyagi SC
Cell Biochem Biophys; 2009; 55(3):153-62. PubMed ID: 19669742
[TBL] [Abstract][Full Text] [Related]
19. The role of homocysteine in bone remodeling.
Vacek TP; Kalani A; Voor MJ; Tyagi SC; Tyagi N
Clin Chem Lab Med; 2013 Mar; 51(3):579-90. PubMed ID: 23449525
[TBL] [Abstract][Full Text] [Related]
20. Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus.
Sen U; Tyagi N; Moshal KS; Kartha GK; Rosenberger D; Henderson BC; Joshua IG; Tyagi SC
Antioxid Redox Signal; 2007 Jul; 9(7):971-8. PubMed ID: 17508918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
